Your browser doesn't support javascript.
loading
Assessment of cardiac allograft systolic function by global longitudinal strain: From donor to recipient.
DeVore, Adam D; Alenezi, Fawaz; Krishnamoorthy, Arun; Ersboll, Mads; Samsky, Marc D; Schulte, Phillip J; Patel, Chetan B; Rogers, Joseph G; Milano, Carmelo A; Velazquez, Eric J; Khouri, Michel G.
Afiliación
  • DeVore AD; Duke Clinical Research Institute, Durham, NC, USA.
  • Alenezi F; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Krishnamoorthy A; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Ersboll M; Duke Clinical Research Institute, Durham, NC, USA.
  • Samsky MD; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Schulte PJ; Department of Cardiology, The Heart Centre, University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Patel CB; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Rogers JG; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Milano CA; Duke Clinical Research Institute, Durham, NC, USA.
  • Velazquez EJ; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Khouri MG; Duke Clinical Research Institute, Durham, NC, USA.
Clin Transplant ; 31(5)2017 05.
Article en En | MEDLINE | ID: mdl-28294407
ABSTRACT

BACKGROUND:

Cardiac allografts are routinely evaluated by left ventricular ejection fraction (LVEF) before and after transplantation. However, myocardial deformation analyses with LV global longitudinal strain (GLS) are more sensitive for detecting impaired LV myocardial systolic performance compared with LVEF.

METHODS:

We analyzed echocardiograms in 34 heart donor-recipient pairs transplanted at Duke University from 2000 to 2013. Assessments of allograft LV systolic function by LVEF and/or LV GLS were performed on echocardiograms obtained pre-explanation in donors and serially in corresponding recipients.

RESULTS:

Donors had a median LVEF of 55% (25th, 75th percentile, 54% to 60%). Median donor LV GLS was -14.6% (-13.7 to -17.3%); LV GLS was abnormal (ie, >-16%) in 68% of donors. Post-transplantation, LV GLS was further impaired at 6 weeks (median -11.8%; -11.0 to -13.4%) and 3 months (median -11.4%; -10.3 to -13.9%) before recovering to pretransplant levels in follow-up. Median LVEF remained ≥50% throughout follow-up. We found no association between donor LV GLS and post-transplant outcomes, including all-cause hospitalization and mortality.

CONCLUSIONS:

GLS demonstrates allograft LV systolic dysfunction in donors and recipients not detected by LVEF. The clinical implications of subclinical allograft dysfunction detected by LV GLS require further study.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Donantes de Tejidos / Disfunción Ventricular Izquierda / Insuficiencia Cardíaca Sistólica Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Transplant Asunto de la revista: TRANSPLANTE Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Donantes de Tejidos / Disfunción Ventricular Izquierda / Insuficiencia Cardíaca Sistólica Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Transplant Asunto de la revista: TRANSPLANTE Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos